Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1963 1
1964 1
1975 1
1976 1
1989 2
1990 1
1991 3
1992 11
1993 5
1994 7
1995 6
1996 3
1997 5
1998 5
1999 1
2000 2
2001 2
2002 7
2003 6
2004 7
2005 11
2006 9
2007 9
2008 10
2009 10
2010 18
2011 6
2012 4
2013 5
2014 8
2015 7
2016 7
2017 7
2018 8
2019 4
2020 3
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

191 results
Results by year
Filters applied: . Clear all
Page 1
Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial.
Sternberg CN, Davis ID, Mardiak J, Szczylik C, Lee E, Wagstaff J, Barrios CH, Salman P, Gladkov OA, Kavina A, Zarbá JJ, Chen M, McCann L, Pandite L, Roychowdhury DF, Hawkins RE. Sternberg CN, et al. Among authors: hawkins re. J Clin Oncol. 2010 Feb 20;28(6):1061-8. doi: 10.1200/JCO.2009.23.9764. Epub 2010 Jan 25. J Clin Oncol. 2010. PMID: 20100962 Clinical Trial.
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.
Armstrong AJ, Halabi S, Eisen T, Broderick S, Stadler WM, Jones RJ, Garcia JA, Vaishampayan UN, Picus J, Hawkins RE, Hainsworth JD, Kollmannsberger CK, Logan TF, Puzanov I, Pickering LM, Ryan CW, Protheroe A, Lusk CM, Oberg S, George DJ. Armstrong AJ, et al. Among authors: hawkins re. Lancet Oncol. 2016 Mar;17(3):378-388. doi: 10.1016/S1470-2045(15)00515-X. Epub 2016 Jan 13. Lancet Oncol. 2016. PMID: 26794930 Free PMC article. Clinical Trial.
Discovery of antibodies.
Llewelyn MB, Hawkins RE, Russell SJ. Llewelyn MB, et al. Among authors: hawkins re. BMJ. 1992 Nov 21;305(6864):1269-72. doi: 10.1136/bmj.305.6864.1269. BMJ. 1992. PMID: 1477573 Free PMC article. Review.
Abdominal vascular catastrophes.
Eldrup-Jorgensen J, Hawkins RE, Bredenberg CE. Eldrup-Jorgensen J, et al. Among authors: hawkins re. Surg Clin North Am. 1997 Dec;77(6):1305-20. doi: 10.1016/s0039-6109(05)70619-8. Surg Clin North Am. 1997. PMID: 9431341 Review.
Cancer vaccines and immunotherapy.
Dermime S, Armstrong A, Hawkins RE, Stern PL. Dermime S, et al. Among authors: hawkins re. Br Med Bull. 2002;62:149-62. doi: 10.1093/bmb/62.1.149. Br Med Bull. 2002. PMID: 12176857 Review.
Principles of antibody therapy.
Russell SJ, Llewelyn MB, Hawkins RE. Russell SJ, et al. Among authors: hawkins re. BMJ. 1992 Dec 5;305(6866):1424-9. doi: 10.1136/bmj.305.6866.1424. BMJ. 1992. PMID: 1486312 Free PMC article. Review.
Overcoming the toxicity hurdles of genetically targeted T cells.
Casucci M, Hawkins RE, Dotti G, Bondanza A. Casucci M, et al. Among authors: hawkins re. Cancer Immunol Immunother. 2015 Jan;64(1):123-30. doi: 10.1007/s00262-014-1641-9. Epub 2014 Dec 9. Cancer Immunol Immunother. 2015. PMID: 25488419 Review.
Engineering T cells for cancer therapy.
Mansoor W, Gilham DE, Thistlethwaite FC, Hawkins RE. Mansoor W, et al. Among authors: hawkins re. Br J Cancer. 2005 Nov 14;93(10):1085-91. doi: 10.1038/sj.bjc.6602839. Br J Cancer. 2005. PMID: 16251873 Free PMC article. Review.
191 results